Healthcare DIVE April 26, 2018
Dive Brief:
- Private equity firm Aspire Universal and Penn Medicine Lancaster General Health are partnering on a venture to speed development and commercialization of personalized devices and medical practices.
- The newly launched Aspire Ventures Precision Medicine Fund finances devices and therapies that leverage artificial intelligence and the internet-of-things to create affordable solutions on a “massive scale,” Aspire said in announcing the deal.
- The goal is to advance population health with AI- and IoT-enabled precision medicine technologies that could have national or global impact.
LG Health clinicians and Aspire will work together to synthesize data and fast-track products through clinical trials and FDA approval. Through the Smart Health...
Today's Sponsors
Today's Sponsor